{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:47:16Z","timestamp":1648914436758},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1053\/jarr.2002.34839","type":"journal-article","created":{"date-parts":[[2002,8,29]],"date-time":"2002-08-29T19:51:36Z","timestamp":1030650696000},"page":"153-158","source":"Crossref","is-referenced-by-count":1,"title":["Introduction: Emerging therapies derived from the molecular pathogenesis of secondary hyperparathyroidism in ESRD patients"],"prefix":"10.1053","volume":"9","author":[{"given":"L. Darryl","family":"Quarles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T15:55:55Z","timestamp":1554911755000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mosby.com\/scripts\/om.dll\/serve?action=searchDB&searchDBfor=art&artType=abs&id=ajarr0090153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":0,"journal-issue":{"issue":"3"},"alternative-id":["10.1053\/jarr.2002.34839"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2002.34839","relation":{},"ISSN":["1073-4449"],"issn-type":[{"value":"1073-4449","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]},"article-number":"ajarr0090153"}}